Welcome to Dynamic Entropy Technology LLC
Our Business & Products
Contract Research & Development Services
Wound-healing Collagen Dressings (Trademark Collagenized Dressings™)
Biomass and biochemicals (including biofuels)
Dr. Mark Feng
To develop new technologies in health sciences for better life of human beings through innovations and technology transfer
To provide R&D services for government, universities, and industries.
Our Key Advantages
Over 20 Years of Experiences
Inventor of multiple U.S. Patents
Short turnaround time
Low indirect cost (<40%)
Drug, gene and vaccine delivery (Formulation)
Wound-healing dressings development and fabrication
Delivery substrates from aligned polymer biomaterials for tissue repair
Oral, intranasal, transdermal, intravenous, intramuscular, intracranial, intraosseous delivery
Tissue engineering and regeneration
Chemical Reactors (Batch & Continuous), Furnace, Catalyst Manufacturing, Chromatography, Electrophoresis, Biomaterial /nanoparticle characterization, Microscopies, Emulsions, Lipid Extrusion and sonication, ISO9001:2015, GLP, cGMP, ISO1485 to be certified.
Pilot plant scale biomass utilization and biofuel production
On October 2020, DET is awarded a Phase I small business technology transfer (STTR) grant from NSF ($256,000). The work is to develop an intranasal nano vaccine for COVID-19.
On September 2019, we received a Phase I small business technology transfer (STTR) award ($225,000) from NIH. The project is antibacterial/antifungal polymer technology as medical devices for diabetic skin infections.